title: Reoperative sternotomy: minimizing injury without the risks of systemic heparin.
authors.forename: Arun K
authors.initials: AK
authors.lastname: Singh
authors.forename: Gary
authors.initials: G
authors.lastname: Stearns
authors.forename: Andrew
authors.initials: A
authors.lastname: Maslow
authors.forename: William C
authors.initials: WC
authors.lastname: Feng
authors.forename: Carl
authors.initials: C
authors.lastname: Schwartz
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000401:mortality; D002315:Cardiopulmonary Bypass / Q000009:adverse effects* / Q000295:instrumentation / Q000401:mortality; D020099:Coated Materials, Biocompatible; D004867:Equipment Design; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D017052:Hospital Mortality; D006801:Humans; D012086:Reoperation; D018570:Risk Assessment; D012307:Risk Factors; D056346:Sternotomy / Q000009:adverse effects* / Q000401:mortality; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D020099:Coated Materials, Biocompatible; D006493:Heparin